Rank #1437PBYI

Puma Biotechnology Inc

$6.79

1.65% (Daily)

Market Cap

$342.16M

Revenue

$212.00M

Rank by MCap

#1437

Sector

Healthcare

Industry

Biotechnology

CEO

Mr. Alan H. Auerbach

Headquarters

Los Angeles, CA

Employees

172

About Puma Biotechnology Inc

Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company offers NERLYNX, an oral version of neratinib that is used to treat adult patients with early stage HER2-overexpressed/amplified breast cancer; and advanced or metastatic HER2-positive breast cancer when combined with capecitabine. It develops alisertib, a small molecule inhibitor of aurora kinase A for ...